This is the more concentrated option, producing smaller injection volumes for any given dose
In late 2021, Novo Nordisk announced that it was unable to manufacture enough semaglutide to fill some prescriptions
And while they can temporarily reduce inflammation, they also come with downsides: Cartilage degradation over time Reduced joint stability Diminishing returns with repeat use BPC-157 doesnt work the same way
ER-associated degradation in protein quality control and cellular regulation
They contribute to collagen production, matrix organisation and tendon structure
Why We Like the Combination of BPC-157 With GHK-Cu and NAD+ In addition to BPC-157 , PushPatch is a strategic combination of: GHK-Cu (Copper Peptide) supports collagen production and skin regeneration NAD+ impacts so many aspects of health, including supporting cellular energy and resilience Think of it like this: BPC-157 helps signal repair and recovery GHK-Cu supports structural rebuilding (e.g., skin damage from sunburn) NAD+ provides the cellular energy needed for repair and resilience, and many people notice that increases in NAD+ lead to improved energy, focus, and recovery
